ANAVEX2-73 Study in Parkinson's Disease Dementia

Clinical trial NCT03774459 · COMPLETED

Trial details

NCT number: NCT03774459
Sponsor: Anavex Life Sciences Corp.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinsons Disease With Dementia

Start date: 2018-07-09
Primary completion: 2020-09-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.